🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Zhaojun Qiu

Fujian Medical University

ORCID: 0000-0001-8582-5068

Also affiliated with First Affiliated Hospital of Fujian Medical University

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity”.

The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity

Nature Communications(2024)10.1038/s41467-024-48076-9

N/A

0DataRank · unranked

19 citations

Adrian Oo, Yujie Liu, Zhaojun Qiu, Yaogang Zhong, Na Li +12 more

PPP2R2A insufficiency enhances PD-L1 immune checkpoint blockade efficacy in lung cancer through cGAS-STING activation

Journal of Clinical Investigation(2025)10.1172/jci193354

N/A

0DataRank · unranked

5 citations

No Joon Song, Anqi Li, Deepika Singh, Chandra Bhushan Prasad, Chunhong Yan +6 more

CD40 drives tumor growth in non-small cell lung cancer via non-canonical immune-independent mechanisms

Cancer Letters(2025)10.1016/j.canlet.2025.218151

N/A

0DataRank · unranked

0 citations

Chandra Bhushan Prasad, Zhaojun Qiu, Deepika Singh, Nicholas L. Bean, Shravya Honne +6 more